Filara BioMed SRL secures contract for Immune sera and immunoglobulins IMMUNOCARD CF 148 C4 Materials reagents consumables and other similar products required for high-performance fundamental research within the Project

Romania, June 10 -- Romania based Filara BioMed SRL has secured contract from Operator SEAP for Immune sera and immunoglobulins IMMUNOCARD CF 148 C4 Materials reagents consumables and other similar products required for high-performance fundamental research within the Project . The value of the contract is worth 110000 RON .

Published by HT Digital Content Services with permission from Pivotal Sources....